Soft-tissue adhesives are an attractive choice for device immobilization by nonsuturing methods. [8] Three glue-type adhesives have been introduced: cyanoacrylate, [9] gelatin-resorcinol-formaldehyde, [10] and fibrin. [11] Although these materials are easily spread over the entire contact area and infiltrated into ruptured tissues, their biocompatibility (for cyanoacrylate and gelatin-resorcinol-formaldehyde adhesives) or bonding strength (for fibrin adhesives) is limited. [8,12] Another strategy is the attachment of materials with soft-tissue adhesive properties to the implantable devices themselves. Some bone-substitute materials, such as titanium (Ti) and hydroxyapatite with excellent osteoconductivity, also strongly adhere to soft tissues. [13,14] Although the adhesive properties of non-bioresorbable bone-substitute materials are sufficient to immobilize an implantable device, the clinical applicability of these materials is limited by their non-bioresorbable property. In real applications, the device must be both attachable and detachable. Ideally, a material for clinical application should be both strongly adhesive and bioresorbable. Octacalcium phosphate (OCP), a main mineral composite in immature biological bone, [15,16] exhibits excellent biocompatibility and can be replaced by bone through metabolic processes. [17] Furthermore, OCP has good formability into blocks or coating. [18,19] However, the application of OCP as a soft tissue adhesive has never been explored.